RNA-protein interactions could lead to new coronavirus drug targets
UC researchers identify viral processes key to broader coronavirus treatments
By Iqbal Pittalwala |
| Health
Human neural stem cells found to be susceptible to SARS-CoV-2 variants
Findings raise concerns about infection during early brain development
By Iqbal Pittalwala |
| Health
Early human embryonic cells may be vulnerable to SARS-CoV-2 infection
Study finds early-stage ectoderm cells are especially susceptible, raising questions about potential developmental risks
By Iqbal Pittalwala |
| Health
Genetic mutation linked to higher SARS-CoV-2 risk
UC Riverside-led research has therapeutic implications for COVID-19 treatment
By Iqbal Pittalwala |
| Health
New vaccine design uses immunity against influenza to offer faster protection against emerging pathogens
Strategy developed by UC Riverside-led research team speeds up production of antibodies against COVID-19
By Iqbal Pittalwala |
| Health
UCR biomedical scientist joins international SARS-CoV-2 group assembled by NIAID
SAVE focuses on mutations in SARS-CoV-2 and emerging virus variants
By Iqbal Pittalwala |
| Health